Fungal keratitis: A review of clinical presentations, treatment strategies and outcomes
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Infectious keratitis is a significant cause of corneal blindness worldwide. Although less prevalent in the developed world, cases of fungal keratitis account for almost half of all keratitis cases, occurring in the developing countries. These cases are one of the most refractory types of infectious keratitis and present various challenges to the treating physician such as delayed presentation, long waiting time for culture positivity, limited availability effective antifungal drugs, prolonged duration for response to therapy, a highly variable spectrum of anti-fungal drug sensitivity and a high recurrence rate following keratoplasty. The advent of rapid diagnostic tools, molecular methods, in vitro anti-fungal drug sensitivity testing, alternatives to natamycin, targeted drug delivery and most importantly the results of large randomized controlled trials have significantly improved our understanding and approach towards the diagnosis and management of cases with fungal keratitis. Overall, Aspergillus and Fusarium species are the most common causes ones of fungal keratitis. History of antecedent trauma is a significant predisposing factor. Corneal scrapings for microscopic evaluation and culture preparation, is the standard of care for establishing the diagnosis of fungal keratitis. Molecular identification of cultures offers accurate identification of fungal pathogens, especially the rare species. Natamycin is an approved first-line drug. Voriconazole is the best alternative, especially for non-fusarium cases. Management involves administration of drugs usually by a combination of various routes, the treatment regimen being individualized depending upon the response to therapy. Photodynamic therapy is a newer treatment modality, being tried for non-responsive cases, before resorting to a therapeutic graft.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,785
Corneal blindness: a global perspective.
Whitcher, J. P., Srinivasan, M., & Upadhyay, M. P. (2001) · Europe PMC (PubMed Central) · Cited by 1,563
Podust, L. M., Poulos, T. L., & Waterman, M. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061562898 · Cited by 531
Mycotic keratitis: epidemiology, diagnosis and management
Thomas, P. A., & Kaliamurthy, J. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12126 · Cited by 495
Terbinafine: Mode of action and properties of the squalene epoxidase inhibition
RYDER, N. S. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb00001.x · Cited by 435
Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation Regimens
Purkins, L., Wood, N., Ghahramani, P., Greenhalgh, K., Allen, M. J., & Kleinermans, D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2546-2553.2002 · Cited by 415
Diekema, D. J., Messer, S. A., Hollis, R. J., Jones, R. N., & Pfaller, M. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3623-3626.2003 · Cited by 371
The Mycotic Ulcer Treatment Trial: A Randomized Trial Comparing Natamycin vs Voriconazole
Prajna, N. V., Krishnan, T., Mascarenhas, J., Rajaraman, R., Prajna, L., Srinivasan, M., Raghavan, A., Oldenburg, C. E., Ray, K. J., Zegans, M. E., et al. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.1497 · Cited by 348
Concepts and Principles of Photodynamic Therapy as an Alternative Antifungal Discovery Platform
Dai, T., Fuchs, B. B., Coleman, J. J., Prates, R. A., Astrakas, C., St. Denis, T. G., Ribeiro, M. S., Mylonakis, E., Hamblin, M. R., & Tegos, G. P. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00120 · Cited by 295
Srinivasan, M. (2004) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200408000-00008 · Cited by 289
Metadata
- Authors
- Sharma, N., Bagga, B., Singhal, D., Nagpal, R., Kate, A., Saluja, G., & Maharana, P. K.
- Venue
- The Ocular Surface
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 24
- Pages
- 22-30
- ISSN
- 1542-0124 (ISSN-L)
- OpenAlex
- W4200075298
- Cited by
- 233
- References
- 46
- FWCI
- 20.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fungal keratitis: A review of clinical presentations, treatment strategies and outcomes. https://app.cochat.ai/papers/10.1016/j.jtos.2021.12.001
- The paper
- Sharma, N., Bagga, B., Singhal, D., Nagpal, R., Kate, A., Saluja, G., & Maharana, P. K. (2022). Fungal keratitis: A review of clinical presentations, treatment strategies and outcomes. The Ocular Surface. https://doi.org/10.1016/j.jtos.2021.12.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.